Your browser is old and is not supported. Upgrade for better security.

Venomyx Therapeutics

EpiPen for snakebites: the antivenom of tomorrow!

What Investors Say


What Friends Say

Indie Bio
Venomyx is using biotechnology to eliminate the use of animals from the process of producing antivenom, along with making it available in a portable, easy-to-use injector that makes it seem like the Epi-Pen for Snake Bites.
Megan Molteni Writer for WIRED
For close to 100 years, antivenom production has been a laborious process of snake-milking and horse blood harvesting. But now, with synthetic biology and next-generation sequencing techniques, scientists are pushing the field into the future. Along with education and smart distribution, those advances could help end this global public health crisis.
Simon Cocking Writer for Irish Tech News
Traditionally anti-snake venom is made by taking the venom from a particular snake breed, inserting it into a horse and then extracting the sample from the horse. This takes too much time and requires a lot of manpower. Venomyx hope to finish with phase 1 clinical trials by end of next summer and are expecting commercial rollout by the end of 2019. The product also qualifies for fast track status with the FDA.

In the news

UN Edition Global Online #FiresideChat- Start-ups That Solve Global Challenges - Silicon Valley Style | Global Online #FiresideChats
September 28, 2018
This Sunday - Join the Global Online FiresideChat radio show for a special UN General Assembly edition - Start-ups That Solve Global Challenges By Building Strong, Silicon Valley-Style, Commercial ...
Bacteria Are Brewing Up the Next Generation of Antivenoms
September 28, 2018
Daniel Dempsey was a grad student stationed in the jungles of Monteverde, Costa Rica when he first encountered the danger of a snakebite. The biologist was walking through the forest one day, catching bats to study them for malaria, when he almost stepped on the black, arrow-shaped head of an enormous pit viper-a fer-de-lance.
Startup Stories: Venomyx Therapeutics - Life Science Network
September 28, 2018
Venomyx Therapeutics is developing a universal antivenom called Vipax™ that can treat all snake bite victims.
Watch IndieBio Accelerator's Demo Day Today
September 28, 2018
TechCrunch is pleased to bring you IndieBio's Accelerator's Demo Day today, February 9th at 3:00pm to 5:00pm PST Located in heart of San Francisco, IndieBio is the largest seed-stage biotech accelerator. Twice a year, IndieBio runs a 4-month accelerator. This year's batch of compa...
Innovative new biotechnologies showcased. IndieBio Demo Day reviewed
September 28, 2018
IndieBio help scientists become entrepreneurs. Using biology to change the world. Scientist's mindset are being shifted from academic discovery to product development. The companies at IndieBio tackle existing research issues and create new ideas too. The event took place at Herbst Theatre in San Francisco. 13 companies spoke at this event.
Venomyx Therapeutics
September 28, 2018
At Venomyx we are developing and bringing to market novel antitoxin therapeutics to make treatment safe, effective, and available around the world.
Event Review: Get to Know Your Local Venture Capitalists
June 17, 2017
On June 8 th, 2017, the San Diego Entrepreneur Exchange ( SDEE) hosted an event to get to know your venture capitalists (VC) at the Bella Vista Social Club & Cafe and The Roth Auditorium at the Sanford Consortium for Regenerative Medicine. Barney & Barney and Marsh & McLellan Agency sponsored the event.
An Interview With Daniel Dempsey of Venomyx Therapeutics - IndieBio
February 3, 2017
Photo: Deepankar Roy (left), Daniel Dempsey, and Alexio Capovilla of Venomyx Therapeutics. Just like an Epi-Pen for Snake Bites. Snake bites are one of humanity's oldest medical problems, but they're definitely not a thing of the past-millions of people are bitten by poisonous snakes every year, and if they are lucky, those people are able to get ...
Snake bites and dark chocolate: Biotech startups
February 1, 2017
What do dark chocolate, snake bites, and cats with irritable bowels have in common? They're all being taken on by 13 startups picked by IndieBio.
What People Say